NCM Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
NCM Capital Management's PFE Position: Q1 2026 in Review
NCM Capital Management increased its Pfizer (PFE) stake by 0.02% in Q1 2026, buying an estimated $133 and bringing the position to 26,699 shares worth $750K. The position accounts for 0.27% of the portfolio, ranked #91.
NCM Capital Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.75M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- NCM Capital Management held 26,699 shares of Pfizer worth $750K as of Q1 2026.
- NCM Capital Management bought 5 Pfizer shares in Q1 2026, an estimated $133.
- Pfizer made up 0.27% of NCM Capital Management's portfolio in Q1 2026, its #91 holding.
- NCM Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- NCM Capital Management's Pfizer position peaked at $1.75M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.